A new intensified therapeutic regimen for advanced head and neck squamous cell carcinomas: where does it fit among available treatment options?

Cancer Invest. 2001;19(2):217-8. doi: 10.1081/cnv-100000157.
No abstract available

Publication types

  • Comment
  • Editorial

MeSH terms

  • Carcinoma, Squamous Cell / drug therapy*
  • Carcinoma, Squamous Cell / mortality
  • Carcinoma, Squamous Cell / radiotherapy
  • Carcinoma, Squamous Cell / surgery
  • Combined Modality Therapy
  • Head and Neck Neoplasms / drug therapy*
  • Head and Neck Neoplasms / mortality
  • Head and Neck Neoplasms / radiotherapy
  • Head and Neck Neoplasms / surgery
  • Humans
  • Survival Rate